Insulin glulisine Subcutaneous and Skyrizi (150 MG Dose)
Determining the interaction of Insulin glulisine Subcutaneous and Skyrizi (150 MG Dose) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Skyrizi, Skyrizi topical
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glulisine Subcutaneous-Skyrizi Injection
- Insulin glulisine Subcutaneous-Skyrizi topical
- Insulin glulisine Subcutaneous-Sleep Aid
- Insulin glulisine Subcutaneous-Sleep Aid Tablets
- Insulin glulisine Subcutaneous-Sleepinal
- Insulin glulisine Subcutaneous-Slo-Niacin
- Skyrizi (150 MG Dose)-Insulin human inhaled Inhalation
- Skyrizi (150 MG Dose)-Insulin human regular Injection
- Skyrizi (150 MG Dose)-Insulin inhalation
- Skyrizi (150 MG Dose)-Insulin isophane
- Skyrizi (150 MG Dose)-Insulin isophane and insulin regular
- Skyrizi (150 MG Dose)-Insulin lispro